CADM1 has the potential to activate tumor lysates by NK cells and strong IFN-γ production by CD8+ T cells [28], indicating that CADM1 acts as the communication molecule for immune cells to invoke their immune ability against tumors. The gene discussed is CD8A; the disease is neoplasm.